Bioprocess Containers Market - Trends Forecast Till 2028

Bioprocess Containers Market – Trends Forecast Till 2028

The global bioprocess containers (BPCs) market is projected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a CAGR of 26.3% during the forecast period.

Bioprocess containers are single-use, flexible containers system widely incorporated for handling sterile liquids. Moreover, these containers are employed for vaccine manufacturing and media preparation in the biopharmaceutical industry. Their basic function is to increase the speed of ongoing biopharmaceutical process and aid in storage of sterile fluids. Furthermore, bioprocess containers are cost-effective and are equipped with plastic films, ports, tubing, and fittings. They are readily integrated into a variety of high-performance systems for all steps in the production of biologics.

Growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D and their power density are some of the factors that have supported long-term expansion for Bioprocess Containers Market.

World Health Organization (WHO) officially declared the outbreak of the virus as a pandemic, a mix of established pharmaceutical companies, as well as players in the bioprocess containers market, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Therefore, the growing adoption of single-use technologies for COVID-19 pandemic-related research, coupled with increasing vaccine development by key players, is expected to have a positive impact on the bioprocess containers market.

North America accounted for the largest share of the bioprocess containers market. The large share of North America can be attributed to the presence of an established biopharmaceuticals industry and major players in the region.

Bioprocess Containers Market is segmented into type, application, end user and region.

On the basis of Type

• 2D bioprocess containers
• 3D bioprocess containers

On the basis of Application

• Upstream Processes
• Downstream Processes
• Process Development

On the basis of End-User

• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes.

On the basis of Region

• Asia Pacific
• North America
• Europe
• South America
• Middle East & Africa

Insights are provided for each region and major countries within the regions

Key Players

• Sartorius Stedim Biotech
• Thermo Fisher Scientific
• Danaher Corporation
• Merck Millipore

Recent Developments

• In June 2021, Avantor, Inc. (US) acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. This acquisition helped the company expand its bioproduction footprint in China.
• In April 2021, Sartorius Stedim Biotech (France) opened a new Customer Interaction Center (CIC) in Beijing, China, to expand its presence in China and to meet the high demand from the growing biopharmaceuticals market.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Bioprocess Containers Market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope